Dekstrometorfaani (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dekstrometorfaani" in Finnish language version.

refsWebsite

Global rank Finnish rank

31nih.gov

4^th place

12^th place

22worldcat.org

5^th place

9^th place

20doi.org

2^nd place

10^th place

15web.archive.org

1^st place

4erowid.org

3,887^th place

839^th place

4sciencedirect.com

149^th place

237^th place

3wiley.com

222^nd place

202^nd place

2fimea.fi

low place

165^th place

1medscape.com

719^th place

525^th place

1sigmaaldrich.com

924^th place

631^st place

1pharmacopeia.cn

low place

1mtv.fi

4,646^th place

18^th place

1ts.fi

5,504^th place

23^rd place

1lakemedelsverket.se

low place

1orion.fi

low place

1,890^th place

1europa.eu

68^th place

51^st place

1psychiatryonline.org

4,032^nd place

2,767^th place

1auvelity.com

low place

1paihdelinkki.fi

low place

535^th place

1lycaeum.org

low place

5,113^th place

1if-pan.krakow.pl

low place

1aspetjournals.org

6,663^rd place

2,918^th place

1springer.com

274^th place

418^th place

1spandidos-publications.com

low place

1sciencemag.org

857^th place

545^th place

1maps.org

low place

5,059^th place

1karger.com

4,489^th place

3,260^th place

aspetjournals.org

jpet.aspetjournals.org

Robert N. Pechnick, Russell E. Poland: Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis. The Journal of Pharmacology and Experimental Therapeutics, toukokuu 2004, 309. vsk, nro 2, s. 515–522. PubMed:14742749. doi:10.1124/jpet.103.060038. ISSN 0022-3565. Artikkelin verkkoversio.

auvelity.com

For Major Depressive Disorder (MDD) - AUVELITY (dextromethorphan-bupropion) www.auvelity.com. Viitattu 7.4.2024. (englanniksi)

doi.org

dx.doi.org

B. Kukanich, M. G. Papich: Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs. Journal of Veterinary Pharmacology and Therapeutics, lokakuu 2004, 27. vsk, nro 5, s. 337–341. PubMed:15500572. doi:10.1111/j.1365-2885.2004.00608.x. ISSN 0140-7783. Artikkelin verkkoversio.
R Abdul Manap, C E Wright, A Gregory, A Rostami-Hodjegan, S T Meller, G R Kelm: The antitussive effect of dextromethorphan in relation to CYP2D6 activity. British Journal of Clinical Pharmacology, syyskuu 1999, 48. vsk, nro 3, s. 382–387. PubMed:10510150. doi:10.1046/j.1365-2125.1999.00029.x. ISSN 0306-5251. Artikkelin verkkoversio.
Jasbir D. Upadhyaya, Nisha Singh, Anurag S. Sikarwar, Raja Chakraborty, Sai P. Pydi, Rajinder P. Bhullar: Dextromethorphan Mediated Bitter Taste Receptor Activation in the Pulmonary Circuit Causes Vasoconstriction. PLoS ONE, 23.10.2014, 9. vsk, nro 10. PubMed:25340739. doi:10.1371/journal.pone.0110373. ISSN 1932-6203. Artikkelin verkkoversio.
Hamilton Morris, Jason Wallach: From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, heinäkuu 2014, 6. vsk, nro 7-8, s. 614–632. PubMed:24678061. doi:10.1002/dta.1620. ISSN 1942-7611. Artikkelin verkkoversio.
Alyn Morice, Peter Kardos: Comprehensive evidence-based review on European antitussives. BMJ Open Respiratory Research, 5.8.2016, 3. vsk, nro 1. PubMed:27547407. doi:10.1136/bmjresp-2016-000137. ISSN 2052-4439. Artikkelin verkkoversio.
Donald C. Bolser: Cough Suppressant and Pharmacologic Protussive Therapy. Chest, tammikuu 2006, 129. vsk, nro 1 Suppl, s. 238S–249S. PubMed:16428717. doi:10.1378/chest.129.1_suppl.238S. ISSN 0012-3692. Artikkelin verkkoversio.
Nick Zagorski: FDA Approves Rapid-Acting Oral Antidepressant. Psychiatric News, 24.10.2022. doi:10.1176/appi.pn.2022.11.11.13. Artikkelin verkkoversio. en
Susan J. Keam: Dextromethorphan/Bupropion: First Approval. CNS Drugs, 27.10.2022, 36. vsk, nro 11, s. 1229–1238. doi:10.1007/s40263-022-00968-4. ISSN 1172-7047. Artikkelin verkkoversio.
Brian McCarthy, Hannah Bunn, Morgan Santalucia, Charlotte Wilmouth, Andrew Muzyk, Colin M. Smith: Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder. Clinical Psychopharmacology and Neuroscience, 17.7.2023, 21. vsk, nro 4, s. 609. PubMed:37859435. doi:10.9758/cpn.23.1081. Artikkelin verkkoversio. en
Jarrett M Burns, Edward W Boyer: Antitussives and substance abuse. Substance Abuse and Rehabilitation, 6.11.2013, nro 4, s. 75–82. PubMed:24648790. doi:10.2147/SAR.S36761. ISSN 1179-8467. Artikkelin verkkoversio.
Katja Strauch, Ursula Lutz, Nataly Bittner, Werner K. Lutz: Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles. Food and Chemical Toxicology, elokuu 2009, 47. vsk, nro 8, s. 1928–1935. PubMed:19445995. doi:10.1016/j.fct.2009.05.004. ISSN 1873-6351. Artikkelin verkkoversio.
Robert N. Pechnick, Russell E. Poland: Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis. The Journal of Pharmacology and Experimental Therapeutics, toukokuu 2004, 309. vsk, nro 2, s. 515–522. PubMed:14742749. doi:10.1124/jpet.103.060038. ISSN 0022-3565. Artikkelin verkkoversio.
B. Girennavar, G. K. Jayaprakasha, B. S. Patil: Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins. Journal of Food Science, lokakuu 2007, 72. vsk, nro 8, s. C417–421. PubMed:17995595. doi:10.1111/j.1750-3841.2007.00483.x. ISSN 1750-3841. Artikkelin verkkoversio.
Andrew K. L. Goey, Irma Meijerman, Jos H. Beijnen, Jan H. M. Schellens: The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers. European Journal of Clinical Pharmacology, marraskuu 2013, 69. vsk, nro 11, s. 1883–1890. PubMed:23881421. doi:10.1007/s00228-013-1558-9. ISSN 1432-1041. Artikkelin verkkoversio.
Linda Nguyen, Kelan L. Thomas, Brandon P. Lucke-Wold, John Z. Cavendish, Molly S. Crowe, Rae R. Matsumoto: Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacology & Therapeutics, maaliskuu 2016, nro 159, s. 1–22. PubMed:26826604. doi:10.1016/j.pharmthera.2016.01.016. ISSN 1879-016X. Artikkelin verkkoversio.
Benfang Pu, Yonghua Xue, Qingming Wang, Chunhui Hua, Xinyuan Li: Dextromethorphan provides neuroprotection via anti-inflammatory and anti-excitotoxicity effects in the cortex following traumatic brain injury. Molecular Medicine Reports, syyskuu 2015, 12. vsk, nro 3, s. 3704–3710. PubMed:26004757. doi:10.3892/mmr.2015.3830. ISSN 1791-3004. Artikkelin verkkoversio.
Claire Brown, Malika Fezoui, William M Selig, Carl E Schwartz, James L Ellis: Antitussive activity of sigma-1 receptor agonists in the guinea-pig. British Journal of Pharmacology, tammikuu 2004, 141. vsk, nro 2, s. 233–240. PubMed:14691051. doi:10.1038/sj.bjp.0705605. ISSN 0007-1188. Artikkelin verkkoversio.
J. W. Olney, J. Labruyere, M. T. Price: Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science, 16.6.1989, 244. vsk, nro 4910, s. 1360–1362. PubMed:2660263. doi:10.1126/science.2660263. ISSN 0036-8075. Artikkelin verkkoversio.
K. Hashimoto, S. Tomitaka, N. Narita, Y. Minabe, M. Iyo, S. Fukui: Induction of heat shock protein HSP-70 in rat retrosplenial cortex following administration of dextromethorphan. Environmental Toxicology and Pharmacology, 15.7.1996, 1. vsk, nro 4, s. 235–239. PubMed:21781688. doi:10.1016/1382-6689(96)00016-6. ISSN 1382-6689. Artikkelin verkkoversio.
R. D. Carliss, A. Radovsky, C. P. Chengelis, T. P. O'Neill, D. L. Shuey: Oral administration of dextromethorphan does not produce neuronal vacuolation in the rat brain. Neurotoxicology, heinäkuu 2007, 28. vsk, nro 4, s. 813–818. PubMed:17573115. doi:10.1016/j.neuro.2007.03.009. ISSN 0161-813X. Artikkelin verkkoversio.

erowid.org

Erowid DXM Vault: Basics erowid.org. Arkistoitu . Viitattu 10.12.2017.
Erowid DXM Vault : Effects erowid.org. Arkistoitu . Viitattu 10.12.2017.
Erowid DXM Vault : Dosage erowid.org. Arkistoitu . Viitattu 10.12.2017.
Erowid DXM Vault : DXM FAQ - Chemistry and Extraction erowid.org. Arkistoitu . Viitattu 10.12.2017.

europa.eu

ema.europa.eu

Nuedexta, dekstrometorfaani/kinidiini 2013. European Medicines Agency. Arkistoitu . Viitattu 25.1.2018.

fimea.fi

spc.fimea.fi

Ihmisille tarkoitettujen lääkevalmisteiden valmisteyhteenvedot, ATC-koodi R05DA09 Fimea. Arkistoitu 7.11.2017. Viitattu 5.11.2017.
Ihmisille tarkoitettujen lääkevalmisteiden valmisteyhteenvedot, ATC-koodi R05FA02 Fimea. Arkistoitu . Viitattu 5.11.2017.

if-pan.krakow.pl

Anna Wojtczak, Mariola Rychlik-Sych, Eliza Krochmalska-Ulacha, Jadwiga Skretkowicz: CYP2D6 phenotyping with dextromethorphan. Pharmacological reports, marraskuu 2007, 59. vsk, nro 6, s. 734–738. PubMed:18195464. ISSN 1734-1140. Artikkelin verkkoversio.

karger.com

Y. Y. Ng, W. L. Lin, T. W. Chen, B. C. Lin, S. H. Tsai, C. C. Chang: Spurious hyperchloremia and decreased anion gap in a patient with dextromethorphan bromide. American Journal of Nephrology, 1992, 12. vsk, nro 4, s. 268–270. PubMed:1481876. ISSN 0250-8095. Artikkelin verkkoversio.

lakemedelsverket.se

Läkemedelsverket: DXM får inte säljas i Sverige - Läkemedelsverket lakemedelsverket.se. Arkistoitu 11.3.2018. Viitattu 19.3.2018. (ruotsiksi)

lycaeum.org

DXM Tips and Tricks lycaeum.org. Arkistoitu . Viitattu 10.12.2017.

maps.org

Jansen, Karl: Ketamine: dreams and realities, s. 240. Sarasota, FL: Multidisciplinary Association for Psychedelic Studies, 2004. OCLC: 537443502. ISBN 0966001974. Teoksen verkkoversio.

medscape.com

reference.medscape.com

Balminil DM, Benylin DM (dextromethorphan) dosing, indications, interactions, adverse effects, and more. reference.medscape.com. Viitattu 20.3.2018. (englanniksi)

mtv.fi

Tuttu yskänlääke Fimean erikoistarkkailussa – nuoret sekoittavat aineella päänsä mtv.fi. Arkistoitu . Viitattu 24.1.2018.

nih.gov

pubmed.ncbi.nlm.nih.gov

B. Kukanich, M. G. Papich: Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs. Journal of Veterinary Pharmacology and Therapeutics, lokakuu 2004, 27. vsk, nro 5, s. 337–341. PubMed:15500572. doi:10.1111/j.1365-2885.2004.00608.x. ISSN 0140-7783. Artikkelin verkkoversio.
R Abdul Manap, C E Wright, A Gregory, A Rostami-Hodjegan, S T Meller, G R Kelm: The antitussive effect of dextromethorphan in relation to CYP2D6 activity. British Journal of Clinical Pharmacology, syyskuu 1999, 48. vsk, nro 3, s. 382–387. PubMed:10510150. doi:10.1046/j.1365-2125.1999.00029.x. ISSN 0306-5251. Artikkelin verkkoversio.
Jasbir D. Upadhyaya, Nisha Singh, Anurag S. Sikarwar, Raja Chakraborty, Sai P. Pydi, Rajinder P. Bhullar: Dextromethorphan Mediated Bitter Taste Receptor Activation in the Pulmonary Circuit Causes Vasoconstriction. PLoS ONE, 23.10.2014, 9. vsk, nro 10. PubMed:25340739. doi:10.1371/journal.pone.0110373. ISSN 1932-6203. Artikkelin verkkoversio.
Hamilton Morris, Jason Wallach: From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, heinäkuu 2014, 6. vsk, nro 7-8, s. 614–632. PubMed:24678061. doi:10.1002/dta.1620. ISSN 1942-7611. Artikkelin verkkoversio.
Barry K. Logan, Gary Goldfogel, Rebecca Hamilton, James Kuhlman: Five deaths resulting from abuse of dextromethorphan sold over the internet. Journal of Analytical Toxicology, maaliskuu 2009, 33. vsk, nro 2, s. 99–103. PubMed:19239735. ISSN 0146-4760.
Alyn Morice, Peter Kardos: Comprehensive evidence-based review on European antitussives. BMJ Open Respiratory Research, 5.8.2016, 3. vsk, nro 1. PubMed:27547407. doi:10.1136/bmjresp-2016-000137. ISSN 2052-4439. Artikkelin verkkoversio.
Donald C. Bolser: Cough Suppressant and Pharmacologic Protussive Therapy. Chest, tammikuu 2006, 129. vsk, nro 1 Suppl, s. 238S–249S. PubMed:16428717. doi:10.1378/chest.129.1_suppl.238S. ISSN 0012-3692. Artikkelin verkkoversio.
Martin Paspe Cruz: Nuedexta for the Treatment Of Pseudobulbar Affect. Pharmacy and Therapeutics, kesäkuu 2013, 38. vsk, nro 6, s. 325–328. PubMed:23946627. ISSN 1052-1372. Artikkelin verkkoversio.
Brian McCarthy, Hannah Bunn, Morgan Santalucia, Charlotte Wilmouth, Andrew Muzyk, Colin M. Smith: Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder. Clinical Psychopharmacology and Neuroscience, 17.7.2023, 21. vsk, nro 4, s. 609. PubMed:37859435. doi:10.9758/cpn.23.1081. Artikkelin verkkoversio. en
Jarrett M Burns, Edward W Boyer: Antitussives and substance abuse. Substance Abuse and Rehabilitation, 6.11.2013, nro 4, s. 75–82. PubMed:24648790. doi:10.2147/SAR.S36761. ISSN 1179-8467. Artikkelin verkkoversio.
Katja Strauch, Ursula Lutz, Nataly Bittner, Werner K. Lutz: Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles. Food and Chemical Toxicology, elokuu 2009, 47. vsk, nro 8, s. 1928–1935. PubMed:19445995. doi:10.1016/j.fct.2009.05.004. ISSN 1873-6351. Artikkelin verkkoversio.
Anna Wojtczak, Mariola Rychlik-Sych, Eliza Krochmalska-Ulacha, Jadwiga Skretkowicz: CYP2D6 phenotyping with dextromethorphan. Pharmacological reports, marraskuu 2007, 59. vsk, nro 6, s. 734–738. PubMed:18195464. ISSN 1734-1140. Artikkelin verkkoversio.
Robert N. Pechnick, Russell E. Poland: Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis. The Journal of Pharmacology and Experimental Therapeutics, toukokuu 2004, 309. vsk, nro 2, s. 515–522. PubMed:14742749. doi:10.1124/jpet.103.060038. ISSN 0022-3565. Artikkelin verkkoversio.
B. Girennavar, G. K. Jayaprakasha, B. S. Patil: Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins. Journal of Food Science, lokakuu 2007, 72. vsk, nro 8, s. C417–421. PubMed:17995595. doi:10.1111/j.1750-3841.2007.00483.x. ISSN 1750-3841. Artikkelin verkkoversio.
Andrew K. L. Goey, Irma Meijerman, Jos H. Beijnen, Jan H. M. Schellens: The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers. European Journal of Clinical Pharmacology, marraskuu 2013, 69. vsk, nro 11, s. 1883–1890. PubMed:23881421. doi:10.1007/s00228-013-1558-9. ISSN 1432-1041. Artikkelin verkkoversio.
Linda Nguyen, Kelan L. Thomas, Brandon P. Lucke-Wold, John Z. Cavendish, Molly S. Crowe, Rae R. Matsumoto: Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacology & Therapeutics, maaliskuu 2016, nro 159, s. 1–22. PubMed:26826604. doi:10.1016/j.pharmthera.2016.01.016. ISSN 1879-016X. Artikkelin verkkoversio.
Benfang Pu, Yonghua Xue, Qingming Wang, Chunhui Hua, Xinyuan Li: Dextromethorphan provides neuroprotection via anti-inflammatory and anti-excitotoxicity effects in the cortex following traumatic brain injury. Molecular Medicine Reports, syyskuu 2015, 12. vsk, nro 3, s. 3704–3710. PubMed:26004757. doi:10.3892/mmr.2015.3830. ISSN 1791-3004. Artikkelin verkkoversio.
Claire Brown, Malika Fezoui, William M Selig, Carl E Schwartz, James L Ellis: Antitussive activity of sigma-1 receptor agonists in the guinea-pig. British Journal of Pharmacology, tammikuu 2004, 141. vsk, nro 2, s. 233–240. PubMed:14691051. doi:10.1038/sj.bjp.0705605. ISSN 0007-1188. Artikkelin verkkoversio.
J. W. Olney, J. Labruyere, M. T. Price: Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science, 16.6.1989, 244. vsk, nro 4910, s. 1360–1362. PubMed:2660263. doi:10.1126/science.2660263. ISSN 0036-8075. Artikkelin verkkoversio.
K. Hashimoto, S. Tomitaka, N. Narita, Y. Minabe, M. Iyo, S. Fukui: Induction of heat shock protein HSP-70 in rat retrosplenial cortex following administration of dextromethorphan. Environmental Toxicology and Pharmacology, 15.7.1996, 1. vsk, nro 4, s. 235–239. PubMed:21781688. doi:10.1016/1382-6689(96)00016-6. ISSN 1382-6689. Artikkelin verkkoversio.
R. D. Carliss, A. Radovsky, C. P. Chengelis, T. P. O'Neill, D. L. Shuey: Oral administration of dextromethorphan does not produce neuronal vacuolation in the rat brain. Neurotoxicology, heinäkuu 2007, 28. vsk, nro 4, s. 813–818. PubMed:17573115. doi:10.1016/j.neuro.2007.03.009. ISSN 0161-813X. Artikkelin verkkoversio.
Y. Y. Ng, W. L. Lin, T. W. Chen, B. C. Lin, S. H. Tsai, C. C. Chang: Spurious hyperchloremia and decreased anion gap in a patient with dextromethorphan bromide. American Journal of Nephrology, 1992, 12. vsk, nro 4, s. 268–270. PubMed:1481876. ISSN 0250-8095. Artikkelin verkkoversio.

ncbi.nlm.nih.gov

R Abdul Manap, C E Wright, A Gregory, A Rostami-Hodjegan, S T Meller, G R Kelm: The antitussive effect of dextromethorphan in relation to CYP2D6 activity. British Journal of Clinical Pharmacology, syyskuu 1999, 48. vsk, nro 3, s. 382–387. PubMed:10510150. doi:10.1046/j.1365-2125.1999.00029.x. ISSN 0306-5251. Artikkelin verkkoversio.
Jasbir D. Upadhyaya, Nisha Singh, Anurag S. Sikarwar, Raja Chakraborty, Sai P. Pydi, Rajinder P. Bhullar: Dextromethorphan Mediated Bitter Taste Receptor Activation in the Pulmonary Circuit Causes Vasoconstriction. PLoS ONE, 23.10.2014, 9. vsk, nro 10. PubMed:25340739. doi:10.1371/journal.pone.0110373. ISSN 1932-6203. Artikkelin verkkoversio.
Alyn Morice, Peter Kardos: Comprehensive evidence-based review on European antitussives. BMJ Open Respiratory Research, 5.8.2016, 3. vsk, nro 1. PubMed:27547407. doi:10.1136/bmjresp-2016-000137. ISSN 2052-4439. Artikkelin verkkoversio.
Donald C. Bolser: Cough Suppressant and Pharmacologic Protussive Therapy. Chest, tammikuu 2006, 129. vsk, nro 1 Suppl, s. 238S–249S. PubMed:16428717. doi:10.1378/chest.129.1_suppl.238S. ISSN 0012-3692. Artikkelin verkkoversio.
Martin Paspe Cruz: Nuedexta for the Treatment Of Pseudobulbar Affect. Pharmacy and Therapeutics, kesäkuu 2013, 38. vsk, nro 6, s. 325–328. PubMed:23946627. ISSN 1052-1372. Artikkelin verkkoversio.
Jarrett M Burns, Edward W Boyer: Antitussives and substance abuse. Substance Abuse and Rehabilitation, 6.11.2013, nro 4, s. 75–82. PubMed:24648790. doi:10.2147/SAR.S36761. ISSN 1179-8467. Artikkelin verkkoversio.
Claire Brown, Malika Fezoui, William M Selig, Carl E Schwartz, James L Ellis: Antitussive activity of sigma-1 receptor agonists in the guinea-pig. British Journal of Pharmacology, tammikuu 2004, 141. vsk, nro 2, s. 233–240. PubMed:14691051. doi:10.1038/sj.bjp.0705605. ISSN 0007-1188. Artikkelin verkkoversio.

pubchem.ncbi.nlm.nih.gov

Pubchem: Dextromethorphan pubchem.ncbi.nlm.nih.gov. Viitattu 20.3.2018. (englanniksi)

pmc.ncbi.nlm.nih.gov

Brian McCarthy, Hannah Bunn, Morgan Santalucia, Charlotte Wilmouth, Andrew Muzyk, Colin M. Smith: Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder. Clinical Psychopharmacology and Neuroscience, 17.7.2023, 21. vsk, nro 4, s. 609. PubMed:37859435. doi:10.9758/cpn.23.1081. Artikkelin verkkoversio. en

orion.fi

spcam.orion.fi

Pakkausseloste: Tietoa käyttäjälle, Resilar 3 mg/ml oraaliliuos spcam.orion.fi. Arkistoitu . Viitattu 24.1.2018.

paihdelinkki.fi

Dekstrometorfaani (DXM) päihdelinkki.fi. 13.6.2014. Arkistoitu . Viitattu 24.1.2018.

pharmacopeia.cn

Reference Tables: Description and Solubility - D pharmacopeia.cn. Arkistoitu . Viitattu 10.12.2017.

psychiatryonline.org

psychnews.psychiatryonline.org

Nick Zagorski: FDA Approves Rapid-Acting Oral Antidepressant. Psychiatric News, 24.10.2022. doi:10.1176/appi.pn.2022.11.11.13. Artikkelin verkkoversio. en

sciencedirect.com

Katja Strauch, Ursula Lutz, Nataly Bittner, Werner K. Lutz: Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles. Food and Chemical Toxicology, elokuu 2009, 47. vsk, nro 8, s. 1928–1935. PubMed:19445995. doi:10.1016/j.fct.2009.05.004. ISSN 1873-6351. Artikkelin verkkoversio.
Linda Nguyen, Kelan L. Thomas, Brandon P. Lucke-Wold, John Z. Cavendish, Molly S. Crowe, Rae R. Matsumoto: Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacology & Therapeutics, maaliskuu 2016, nro 159, s. 1–22. PubMed:26826604. doi:10.1016/j.pharmthera.2016.01.016. ISSN 1879-016X. Artikkelin verkkoversio.
K. Hashimoto, S. Tomitaka, N. Narita, Y. Minabe, M. Iyo, S. Fukui: Induction of heat shock protein HSP-70 in rat retrosplenial cortex following administration of dextromethorphan. Environmental Toxicology and Pharmacology, 15.7.1996, 1. vsk, nro 4, s. 235–239. PubMed:21781688. doi:10.1016/1382-6689(96)00016-6. ISSN 1382-6689. Artikkelin verkkoversio.
R. D. Carliss, A. Radovsky, C. P. Chengelis, T. P. O'Neill, D. L. Shuey: Oral administration of dextromethorphan does not produce neuronal vacuolation in the rat brain. Neurotoxicology, heinäkuu 2007, 28. vsk, nro 4, s. 813–818. PubMed:17573115. doi:10.1016/j.neuro.2007.03.009. ISSN 0161-813X. Artikkelin verkkoversio.

sciencemag.org

science.sciencemag.org

J. W. Olney, J. Labruyere, M. T. Price: Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science, 16.6.1989, 244. vsk, nro 4910, s. 1360–1362. PubMed:2660263. doi:10.1126/science.2660263. ISSN 0036-8075. Artikkelin verkkoversio.

sigmaaldrich.com

Dextromethorphan hydrobromide sigmaaldrich.com. Viitattu 20.3.2018. (englanniksi)

spandidos-publications.com

Benfang Pu, Yonghua Xue, Qingming Wang, Chunhui Hua, Xinyuan Li: Dextromethorphan provides neuroprotection via anti-inflammatory and anti-excitotoxicity effects in the cortex following traumatic brain injury. Molecular Medicine Reports, syyskuu 2015, 12. vsk, nro 3, s. 3704–3710. PubMed:26004757. doi:10.3892/mmr.2015.3830. ISSN 1791-3004. Artikkelin verkkoversio.

springer.com

link.springer.com

Andrew K. L. Goey, Irma Meijerman, Jos H. Beijnen, Jan H. M. Schellens: The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers. European Journal of Clinical Pharmacology, marraskuu 2013, 69. vsk, nro 11, s. 1883–1890. PubMed:23881421. doi:10.1007/s00228-013-1558-9. ISSN 1432-1041. Artikkelin verkkoversio.

ts.fi

Huumeena käytetyn lääkeaineen myynti jatkuu yskänlääkkeissä ts.fi. Arkistoitu 12.3.2018. Viitattu 19.3.2018.

web.archive.org

Reference Tables: Description and Solubility - D pharmacopeia.cn. Arkistoitu . Viitattu 10.12.2017.
Netissä ohjeet: Yskänlääkkeestä saa uuttamalla huumetta Helsingin Sanomat 5.6.2008.
Tuttu yskänlääke Fimean erikoistarkkailussa – nuoret sekoittavat aineella päänsä mtv.fi. Arkistoitu . Viitattu 24.1.2018.
Huumeena käytetyn lääkeaineen myynti jatkuu yskänlääkkeissä ts.fi. Arkistoitu 12.3.2018. Viitattu 19.3.2018.
Läkemedelsverket: DXM får inte säljas i Sverige - Läkemedelsverket lakemedelsverket.se. Arkistoitu 11.3.2018. Viitattu 19.3.2018. (ruotsiksi)
Ihmisille tarkoitettujen lääkevalmisteiden valmisteyhteenvedot, ATC-koodi R05DA09 Fimea. Arkistoitu 7.11.2017. Viitattu 5.11.2017.
Ihmisille tarkoitettujen lääkevalmisteiden valmisteyhteenvedot, ATC-koodi R05FA02 Fimea. Arkistoitu . Viitattu 5.11.2017.
Pakkausseloste: Tietoa käyttäjälle, Resilar 3 mg/ml oraaliliuos spcam.orion.fi. Arkistoitu . Viitattu 24.1.2018.
Nuedexta, dekstrometorfaani/kinidiini 2013. European Medicines Agency. Arkistoitu . Viitattu 25.1.2018.
Erowid DXM Vault: Basics erowid.org. Arkistoitu . Viitattu 10.12.2017.
Erowid DXM Vault : Effects erowid.org. Arkistoitu . Viitattu 10.12.2017.
Dekstrometorfaani (DXM) päihdelinkki.fi. 13.6.2014. Arkistoitu . Viitattu 24.1.2018.
Erowid DXM Vault : Dosage erowid.org. Arkistoitu . Viitattu 10.12.2017.
DXM Tips and Tricks lycaeum.org. Arkistoitu . Viitattu 10.12.2017.
Erowid DXM Vault : DXM FAQ - Chemistry and Extraction erowid.org. Arkistoitu . Viitattu 10.12.2017.

wiley.com

onlinelibrary.wiley.com

B. Kukanich, M. G. Papich: Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs. Journal of Veterinary Pharmacology and Therapeutics, lokakuu 2004, 27. vsk, nro 5, s. 337–341. PubMed:15500572. doi:10.1111/j.1365-2885.2004.00608.x. ISSN 0140-7783. Artikkelin verkkoversio.
Hamilton Morris, Jason Wallach: From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, heinäkuu 2014, 6. vsk, nro 7-8, s. 614–632. PubMed:24678061. doi:10.1002/dta.1620. ISSN 1942-7611. Artikkelin verkkoversio.
B. Girennavar, G. K. Jayaprakasha, B. S. Patil: Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins. Journal of Food Science, lokakuu 2007, 72. vsk, nro 8, s. C417–421. PubMed:17995595. doi:10.1111/j.1750-3841.2007.00483.x. ISSN 1750-3841. Artikkelin verkkoversio.

worldcat.org

B. Kukanich, M. G. Papich: Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs. Journal of Veterinary Pharmacology and Therapeutics, lokakuu 2004, 27. vsk, nro 5, s. 337–341. PubMed:15500572. doi:10.1111/j.1365-2885.2004.00608.x. ISSN 0140-7783. Artikkelin verkkoversio.
R Abdul Manap, C E Wright, A Gregory, A Rostami-Hodjegan, S T Meller, G R Kelm: The antitussive effect of dextromethorphan in relation to CYP2D6 activity. British Journal of Clinical Pharmacology, syyskuu 1999, 48. vsk, nro 3, s. 382–387. PubMed:10510150. doi:10.1046/j.1365-2125.1999.00029.x. ISSN 0306-5251. Artikkelin verkkoversio.
Jasbir D. Upadhyaya, Nisha Singh, Anurag S. Sikarwar, Raja Chakraborty, Sai P. Pydi, Rajinder P. Bhullar: Dextromethorphan Mediated Bitter Taste Receptor Activation in the Pulmonary Circuit Causes Vasoconstriction. PLoS ONE, 23.10.2014, 9. vsk, nro 10. PubMed:25340739. doi:10.1371/journal.pone.0110373. ISSN 1932-6203. Artikkelin verkkoversio.
Hamilton Morris, Jason Wallach: From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, heinäkuu 2014, 6. vsk, nro 7-8, s. 614–632. PubMed:24678061. doi:10.1002/dta.1620. ISSN 1942-7611. Artikkelin verkkoversio.
Barry K. Logan, Gary Goldfogel, Rebecca Hamilton, James Kuhlman: Five deaths resulting from abuse of dextromethorphan sold over the internet. Journal of Analytical Toxicology, maaliskuu 2009, 33. vsk, nro 2, s. 99–103. PubMed:19239735. ISSN 0146-4760.
Alyn Morice, Peter Kardos: Comprehensive evidence-based review on European antitussives. BMJ Open Respiratory Research, 5.8.2016, 3. vsk, nro 1. PubMed:27547407. doi:10.1136/bmjresp-2016-000137. ISSN 2052-4439. Artikkelin verkkoversio.
Donald C. Bolser: Cough Suppressant and Pharmacologic Protussive Therapy. Chest, tammikuu 2006, 129. vsk, nro 1 Suppl, s. 238S–249S. PubMed:16428717. doi:10.1378/chest.129.1_suppl.238S. ISSN 0012-3692. Artikkelin verkkoversio.
Martin Paspe Cruz: Nuedexta for the Treatment Of Pseudobulbar Affect. Pharmacy and Therapeutics, kesäkuu 2013, 38. vsk, nro 6, s. 325–328. PubMed:23946627. ISSN 1052-1372. Artikkelin verkkoversio.
Susan J. Keam: Dextromethorphan/Bupropion: First Approval. CNS Drugs, 27.10.2022, 36. vsk, nro 11, s. 1229–1238. doi:10.1007/s40263-022-00968-4. ISSN 1172-7047. Artikkelin verkkoversio.
Jarrett M Burns, Edward W Boyer: Antitussives and substance abuse. Substance Abuse and Rehabilitation, 6.11.2013, nro 4, s. 75–82. PubMed:24648790. doi:10.2147/SAR.S36761. ISSN 1179-8467. Artikkelin verkkoversio.
Katja Strauch, Ursula Lutz, Nataly Bittner, Werner K. Lutz: Dose-response relationship for the pharmacokinetic interaction of grapefruit juice with dextromethorphan investigated by human urinary metabolite profiles. Food and Chemical Toxicology, elokuu 2009, 47. vsk, nro 8, s. 1928–1935. PubMed:19445995. doi:10.1016/j.fct.2009.05.004. ISSN 1873-6351. Artikkelin verkkoversio.
Anna Wojtczak, Mariola Rychlik-Sych, Eliza Krochmalska-Ulacha, Jadwiga Skretkowicz: CYP2D6 phenotyping with dextromethorphan. Pharmacological reports, marraskuu 2007, 59. vsk, nro 6, s. 734–738. PubMed:18195464. ISSN 1734-1140. Artikkelin verkkoversio.
Robert N. Pechnick, Russell E. Poland: Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis. The Journal of Pharmacology and Experimental Therapeutics, toukokuu 2004, 309. vsk, nro 2, s. 515–522. PubMed:14742749. doi:10.1124/jpet.103.060038. ISSN 0022-3565. Artikkelin verkkoversio.
B. Girennavar, G. K. Jayaprakasha, B. S. Patil: Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins. Journal of Food Science, lokakuu 2007, 72. vsk, nro 8, s. C417–421. PubMed:17995595. doi:10.1111/j.1750-3841.2007.00483.x. ISSN 1750-3841. Artikkelin verkkoversio.
Andrew K. L. Goey, Irma Meijerman, Jos H. Beijnen, Jan H. M. Schellens: The effect of grape seed extract on the pharmacokinetics of dextromethorphan in healthy volunteers. European Journal of Clinical Pharmacology, marraskuu 2013, 69. vsk, nro 11, s. 1883–1890. PubMed:23881421. doi:10.1007/s00228-013-1558-9. ISSN 1432-1041. Artikkelin verkkoversio.
Linda Nguyen, Kelan L. Thomas, Brandon P. Lucke-Wold, John Z. Cavendish, Molly S. Crowe, Rae R. Matsumoto: Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacology & Therapeutics, maaliskuu 2016, nro 159, s. 1–22. PubMed:26826604. doi:10.1016/j.pharmthera.2016.01.016. ISSN 1879-016X. Artikkelin verkkoversio.
Benfang Pu, Yonghua Xue, Qingming Wang, Chunhui Hua, Xinyuan Li: Dextromethorphan provides neuroprotection via anti-inflammatory and anti-excitotoxicity effects in the cortex following traumatic brain injury. Molecular Medicine Reports, syyskuu 2015, 12. vsk, nro 3, s. 3704–3710. PubMed:26004757. doi:10.3892/mmr.2015.3830. ISSN 1791-3004. Artikkelin verkkoversio.
Claire Brown, Malika Fezoui, William M Selig, Carl E Schwartz, James L Ellis: Antitussive activity of sigma-1 receptor agonists in the guinea-pig. British Journal of Pharmacology, tammikuu 2004, 141. vsk, nro 2, s. 233–240. PubMed:14691051. doi:10.1038/sj.bjp.0705605. ISSN 0007-1188. Artikkelin verkkoversio.
J. W. Olney, J. Labruyere, M. T. Price: Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science, 16.6.1989, 244. vsk, nro 4910, s. 1360–1362. PubMed:2660263. doi:10.1126/science.2660263. ISSN 0036-8075. Artikkelin verkkoversio.
K. Hashimoto, S. Tomitaka, N. Narita, Y. Minabe, M. Iyo, S. Fukui: Induction of heat shock protein HSP-70 in rat retrosplenial cortex following administration of dextromethorphan. Environmental Toxicology and Pharmacology, 15.7.1996, 1. vsk, nro 4, s. 235–239. PubMed:21781688. doi:10.1016/1382-6689(96)00016-6. ISSN 1382-6689. Artikkelin verkkoversio.
R. D. Carliss, A. Radovsky, C. P. Chengelis, T. P. O'Neill, D. L. Shuey: Oral administration of dextromethorphan does not produce neuronal vacuolation in the rat brain. Neurotoxicology, heinäkuu 2007, 28. vsk, nro 4, s. 813–818. PubMed:17573115. doi:10.1016/j.neuro.2007.03.009. ISSN 0161-813X. Artikkelin verkkoversio.
Y. Y. Ng, W. L. Lin, T. W. Chen, B. C. Lin, S. H. Tsai, C. C. Chang: Spurious hyperchloremia and decreased anion gap in a patient with dextromethorphan bromide. American Journal of Nephrology, 1992, 12. vsk, nro 4, s. 268–270. PubMed:1481876. ISSN 0250-8095. Artikkelin verkkoversio.